Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Landscape and outcome of TRK fusion-positive cancers
    Meeting Abstract

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): A randomised, open-label, phase 2 trial
    Journal Article

    Tolaney, S. M.; Wardley, A. M.; Zambelli, S.; Hilton, J. F.; Troso-Sandoval, T. A.; Ricci, F.; Im, S. A.; Kim, S. B.; Johnston, S. R.; Chan, A.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States
    Guidelines

    Mohile, S.; Dumontier, C.; Mian, H.; Loh, K. P.; Williams, G. R.; Wildes, T. M.; Boyd, K.; Ramsdale, E.; Pyne, S.; Magnuson, A.; more...
    Journal of Geriatric Oncology (2020)

    Fulltext@MSK | Save
  • Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma
    Journal Article

    Mueller, J. J.; Pedra Nobre, S.; Braxton, K.; Alektiar, K. M.; Leitao, M. M. Jr; Aghajanian, C.; Ellenson, L. H.; Abu-Rustum, N. R.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah’s Witness
    Journal Article

    Rubinstein, M. M.; Goss, C.; Avecilla, S. T.; Dubé, G. P.; Riely, G. J.; Mones, J. V.
    Clinical Case Reports (2020)

    Fulltext@MSK | Save
  • Genomic landscape of uterine sarcomas defined through prospective clinical sequencing
    Journal Article

    Hensley, M. L.; Chavan, S. S.; Solit, D. B.; Murali, R.; Soslow, R.; Chiang, S.; Jungbluth, A. A.; Bandlamudi, C.; Srinivasan, P.; Tap, W. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program
    Meeting Abstract

    McCleary, N. J.; Harmsen, W. S.; VanCutsem, E.; Sobrero, A. F.; Goldberg, R. M.; Tabernero, J.; Seymour, M.; Saltz, L. B.; Giantonio, B. J.; Dirk, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQoL) in monarcHER: Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in HR+, HER2+ advanced breast cancer
    Meeting Abstract

    Tolaney, S. M.; Wardley, A. M.; Zambelli, S.; Hilton, J. F.; Troso-Sandoval, T. A.; Ricci, F.; Im, S. A.; Kim, S. B.; Johnston, S. R. D.; Chan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Capivasertib (AZD5363) in combination with fulvestrant in PTEN-mutant ER+ metastatic breast cancer
    Meeting Abstract

    Smyth, L. M.; Batist, G.; Meric-Bernstam, F.; Kabos, P.; Spanggaard, I.; Lluch, A.; Schram, A.; Varga, A.; Wong, A.; Ambrose, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Factors associated with decreased relative dose intensity in older adults with early-stage breast cancer receiving chemotherapy
    Meeting Abstract

    Sedrak, M. S.; Sun, C. L.; Magnuson, A.; Muss, H.; Freedman, R.; Gross, C. P.; Tew, W. P.; Klepin, H.; Wildes, T. M.; Dotan, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save